Amyris Inc (NASDAQ: AMRS) is having a great day in the market this morning, and for good reason. The company announced that it will be providing a presentation relatively soon.
As you could imagine, the news excited investors, sending the stock on a run for the top. Today, we’ll talk about:
- The coming presentation;
- what we’re seeing from AMRS stock as a result; and
- what we’ll be watching for ahead.
AMRS Announces Coming Presentation
As mentioned above, Amyris is having a great day in the market today after announcing that it will be presenting soon. The news came via press release early this morning.
In the release, the company said that management will be presenting at the Paradigm Capital Biosynthesis Conference on April 15, 2019 in Toronto. AMRS said that the focus of the conference will be to explore the most disruptive technology in the cannabis industry.
Moreover, the company believes that with its proven commercial history and leading technology platform, it is well suited to leverage development and commercialization of high-purity cannabinoids at significantly reduced cost through fermentation.
At the event, the company will discuss its previously disclosed cannabinoid development, licensing and commercialization agreement. The agreement contains $300 million of R&D and milestone payments and a long-term royalty stream. The company will also take part in one on one investor meetings.
In a statement, John Melo, President & CEO at AMRS, had the following to offer:
We’re pleased to share our strategy and progress for cannabis at this conference. We have now completed in our labs the technical performance requirements for our first major milestone for our CBD collaboration and share the excitement of our partner and their commitment to market leadership by enabling some of the world’s leading brands to improve the health and wellness of consumers. We are making very good progress on a solid quarter and we are on track to deliver on the objectives we communicated on our recent earnings call.
What We’re Seeing From The Stock
One of the first lessons that we learn when we start to dig into the market is that the news leads to moves. In the case of Amyris, the news proved to be overwhelmingly positive.
After all, the company will be providing an update on its efforts in the cannabis space, a space that seems to yield quite a bit of investor interest.
Considering this, it’s not surprising to see that excited investors are pushing the stock on a run for the top. As is normally the case, our partners at Trade Ideas were the first to alert us to the gains. Currently (10:50), AMRS is trading at $2.06 per share after a gain of $0.19 per share or 9.84% thus far today.
Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!
What We’ll Be Watching For Ahead
Moving forward, the CNA Finance team will continue to keep a close eye on AMRS. In particular, we’re interested in following the company’s work to expand into the cannabis space as it can lead to incredible growth. Nonetheless, we’ll continue to follow the story closely and bring the news to you as it breaks!
Never Miss The News Again
Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!